Elizabeth Arden (RDEN) Misses Q3 EPS by 39c, Offers Outlook

Elizabeth Arden (NASDAQ: RDEN) reported Q3 EPS of ($0.86), $0.39 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $191.7 million versus the consensus estimate of $194.48 million.

OUTLOOK

The Company currently expects the following for the fourth quarter of fiscal 2015 as compared to the prior year period:

• Net sales increases in the International segment versus the prior year period at constant currency rates with continued declines in celebrity fragrances impacting the North America segment;
• Gross margin expansion due to better sales mix, lower discounts and realization of reduced supply chain and product costs;
• Lower overall selling, general and administrative expenses, with some reinvestment of 2014 Performance Improvement Plan savings to drive future growth;
• Improved EBITDA margins from gross margin expansion and lower selling, general and administrative expenses; and
• For the full fiscal year, stronger cash flow from operations from improved working capital.

For earnings history and earnings-related data on Elizabeth Arden (RDEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c